Differences in Health Care and Palliative Care Use at the End of Life
CHEST · 2024
DOI: 10.1016/j.chest.2024.08.018 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift CHEST, 2024. Verfasst von Angela O Suen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA. Electr…. Hauptthemen laut MEDLINE: Palliative Care, Idiopathic Pulmonary Fibrosis, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, Doris Duke Charitable Foundation.
Themen: Palliativpflege
Abstract (Originalsprache)
BACKGROUND: Patients with lung cancer, idiopathic pulmonary fibrosis (IPF), and COPD have high symptom burden, poor quality of life, and high health care use at the end of life. Although proactive integration of palliative care in lung cancer can improve outcomes, it is unclear whether similar practices have been adopted in COPD and IPF care. RESEARCH QUESTION: Do patients with COPD and IPF have different patterns of health care and palliative care use at the end of life compared with patients with lung cancer? STUDY DESIGN AND METHODS: We retrospectively identified deceased patients with lung cancer, COPD, or IPF with ≥ 1 outpatient visit at the University of California, San Francisco, in the last 6 months of life. We compared outpatient palliative care and opioid prescriptions, inpatient palliative care, hospitalizations, intensive care use, and in-hospital death in the last 6 months of life between each group. We used multivariable logistic regression to calculate adjusted ORs (aORs) of each outcome, with lung cancer as the reference group. RESULTS: Among 1,819 patients, patients with COPD and IPF were more likely to be male and older at the time of death compared with patients with lung cancer. Compared with patients with lung cancer, patients with COPD and IPF showed a lower adjusted odds (P < .001) of receiving outpatient palliative care (COPD: aOR, 0.26 [95% CI, 0.19-0.36]; IPF: aOR, 0.48 [95% CI, 0.32-0.70]), outpatient opioid prescription (COPD: aOR, 0.50 [95% CI, 0.40-0.63]; IPF: aOR, 0.40 [95% CI, 0.29-0.54]), and a higher odds of end-of-life ICU use (COPD: aOR, 2.88 [95% CI, 2.11-3.93]; IPF: aOR, 4.15 [95% CI, 2.66-6.49]). Patients with IPF showed higher odds of receiving inpatient palliative care (aOR: 2.02 [95% CI, 1.30-3.13]; P = .002). INTERPRETATION: This study showed that patients with COPD and IPF are less likely to receive outpatient palliative care and opioid prescriptions and are more likely to use end-of-life intensive care than patients with lung cancer. Further research should explore health system barriers contributing to differences in care patterns to optimize quality of life and to align with patient goals of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: angela.suen@ucsf.edu.
- Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Division of Gerontology, Geriatrics, and Palliative Care, and School of Nursing, University of Alabama at Birmingham, Birmingham, AL; Birmingham Veterans Affai…
- Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA.
- Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA; Department of Medicine, San Francisco VA Medical Center, San Francisco, CA.
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- Doris Duke Charitable Foundation
- National Institutes of Health
Zitieren
APA
Suen, A. O., Bischoff, K., Iyer, A. S., Radhakrishnan, K., Fenton, C., Singer, J. P., Sudore, R. L., Kotwal, A., & Farrand, E. (2024). Differences in Health Care and Palliative Care Use at the End of Life. CHEST. https://doi.org/10.1016/j.chest.2024.08.018
Vancouver
Suen AO, Bischoff K, Iyer AS, Radhakrishnan K, Fenton C, Singer JP, et al. Differences in Health Care and Palliative Care Use at the End of Life. CHEST. 2024. doi:10.1016/j.chest.2024.08.018
BibTeX
@article{Suen2024,
author = {Suen, Angela O and Bischoff, Kara and Iyer, Anand S and Radhakrishnan, Keerthana and Fenton, Cynthia and Singer, Jonathan P and Sudore, Rebecca L and Kotwal, Ashwin and Farrand, Erica},
title = {Differences in Health Care and Palliative Care Use at the End of Life},
journal = {CHEST},
year = {2024},
doi = {10.1016/j.chest.2024.08.018}
}
EUVIMED